'The Liver Meeting 2012', the 63rd annual meeting of the American Association for the Study of Liver Diseases (AASLD), took place in Boston, USA, 9-13th November 2012.

Conference highlights

Telaprevir: study results

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people.

Interferon-free combination

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C.

Boceprevir: managing anaemia

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

aidsmap news from AASLD 2012

← Prev12Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Official conference website

Find out more about the conference and view the programme on the official conference website.

Visit the conference website >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.